Skip to content

Depression: all studies

Page 876 of 1,038: studies 8,751 to 8,760 of 10,380, newest first. Back to the depression overview

Research

2018/7/6/curcumin-breast-cancer-therapeutic-agent-to-replace-allopathic-treatments-with-extensive-side-effects

July 9, 2018 Chu Hsien Lim, Brian D Kangas, Jack Bergman 1 citation

Cancer patients experience a higher rate of depression and anxiety which can result in negative healthcare outcomes. With the limited treatment options available, there has been an interest in using psychedelics such as psilocybin to manage such complications. Recently, two studies demonstrated the

Effects of mindfulness-based stress reduction training on negative emotions in elderly patients with chronic heart failure

Zhonghua xiandai huli zazhi July 6, 2018 Hongxia Zhao, Yuan Yuan, Changying Chen 6 citations

Objective To study the effects of mindfulness-based stress reduction (MBSR) training on the negative emotions in elderly patients with chronic heart failure. Methods A total of 148 cases of elderly patients with chronic heart failure undergoing standard medication therapy for heart failure from February 2015 to February 2016 in the Internal Medicine-Cardiovascular Department of the First...

Mindfulness-Based Cognitive Therapy for Bipolar Disorder: A Systematic Review

Journal of Affective Disorders July 6, 2018 David Lovas, Zev Schuman-Olivier

Background: Persisting high levels of relapse, morbidity and mortality in bipolar disorder (BD) in spite of first-line, evidence-based psychopharmacology has spurred development and research on adjunctive psychotherapies. Mindfulness-based cognitive therapy (MBCT) is an emerging psychotherapy that has shown benefit in related and comorbid conditions such as major depressive, anxiety, and...

Psychedelics as anti-inflammatory agents

International Review of Psychiatry July 4, 2018 Thomas W. Flanagan, Charles D. Nichols 263 citations

Serotonin (5-hydroxytryptamine, 5-HT)2A receptor agonists have recently emerged as promising new treatment options for a variety of disorders. The recent success of these agonists, also known as psychedelics, like psilocybin for the treatment of anxiety, depression, obsessive-compulsive disorder (OCD), and addiction, has ushered in a renaissance in the way these compounds are perceived in the...

Therapeutic use of classic psychedelics to treat cancer-related psychiatric distress

International Review of Psychiatry July 4, 2018 Stephen Ross 103 citations

Cancer is highly prevalent and one of the leading causes of global morbidity and mortality. Psychological and existential suffering is common in cancer patients, associated with poor psychiatric and medical outcomes. Promising early-phase clinical research (1960s to early 1970s) suggested a therapeutic signal for serotoninergic psychedelics (e.g. psilocybin, LSD) in treating cancer-related...

The Effect of Spiritual Care on the Body Image of Patients Undergoing Amputation due to Type 2 Diabetes: A Randomized Clinical Trial.

Iranian Journal of Nursing and Midwifery Research July 1, 2018 Malihe Imeni, Fakhri Sabouhi, Parvaneh Abazari et al.

Background: Body image, as an important factor in quality of life (QOL) satisfaction, in amputee patients is strongly affected by amputation, which can put the patient at risk of psychological disorders such as depression. Hence, this study was conducted to investigate the effect of spiritual care on body image in patients with type 2 diabetes-related amputation. Materials and methods: In this...

Mindfulness-based relapse prevention combined with virtual reality cue exposure for methamphetamine use disorder: Study protocol for a randomized controlled trial.

Contemporary Clinical Trials July 2018 Xi Jing Chen, Dong Mei Wang, Li Dan Zhou et al.

Mindfulness-based relapse prevention (MBRP) is a method that combines cognitive behavioral relapse prevention with mindfulness practice. Research suggests that MBRP can effectively reduce withdrawal/craving in people with substance use disorder (SUD). An important part of MBRP is to practice mindfulness meditation to cope with high-risk situations for relapse, such as stimuli and situations...

DOI: 10.1016/j.cct.2018.04.006 (opens in new tab) Full text (opens in new tab) Substance use disorder Cue exposure Methamphetamine addiction Randomized controlled trial +1

Calcium/Calmodulin-Dependent Protein Kinase II and Eukaryotic Elongation Factor 2 Kinase Pathways Mediate the Antidepressant Action of Ketamine.

Biological Psychiatry July 1, 2018 Chinnakkaruppan Adaikkan, Elham Taha, Iliana Barrera et al.

Ketamine is an N-methyl-D-aspartate receptor antagonist, which on administration produces fast-acting antidepressant responses in patients with major depressive disorder. Yet, the mechanism underlying the antidepressant action of ketamine remains unclear. To unravel the mechanism of action of ketamine, we treated wild-type C57BL/6 mice with calcium/calmodulin-dependent protein kinase II...

Astrocytes activation contributes to the antidepressant-like effect of ketamine but not scopolamine.

Pharmacology, Biochemistry, and Behavior July 2018 Yun Wang, Liming Xie, Ce Gao et al.

Depression is a common, debilitating mood disorder, but currently available antidepressants have several major drawbacks. Both ketamine and scopolamine attract more and more attention due to their rapid and sustained antidepressant activities. However, the molecular and cellular mechanism that underlies the therapeutic action of ketamine and scopolamine still remain to be elucidated....

Out-of-body experience in vestibular disorders - A prospective study of 210 patients with dizziness.

Cortex July 1, 2018 Christophe Lopez, Maya Elzière

Out-of-body experiences (OBEs) are states during which people experience their centre of awareness as located outside of their physical body, along with the sensation of seeing the environment from an elevated viewpoint. OBE is encountered in epilepsy, migraine and depersonalization, and it is not an uncommon experience in the general population. Current neuroscientific models of bodily...

DOI: 10.1016/j.cortex.2017.05.026 (opens in new tab) Full text (opens in new tab) Bodily self-consciousness Out-of-body experience Self-location Sensory conflict +1